期刊文献+

Changes of ECM and CAM gene expression profile in the cirrhotic liver after HCV infection: Analysis by cDNA expression array 被引量:2

Changes of ECM and CAM gene expression profile in the cirrhotic liver after HCV infection: Analysis by cDNA expression array
下载PDF
导出
摘要 AIM: We aimed to observe the expression of extracellular matrix (ECM) and cellular adhesion molecules (CAM) in cirrhotic liver tissues after hepatitis C virus (HCV) infection. METHODS: Twelve patients with post HCV inflammatory liver cirrhosis were selected to evaluate their liver function and other virological, pathological parameters. Then three specimens of cirrhotic patients whose health assessment results and laboratory data were similar and three normal liver specimens explanted from liver grafts prepared for liver transplantation were chosen for investigating gene expression of ECM and CAM using cDNA expression array. RESULTS: The cDNA array assay revealed 36.7% (36/96)of genes with changes, in which 26.3% (26/96) was up regulated and 10.1% (10/96) was down-regulated. Integrin (ITGA), collagen (COL), ADAMTS were identified as the characteristic changes of ECM and CAM gene expression levels. ITGA were demonstrated β1 and β2 sub-section changed in liver cirrhosis.CONCLUSION: ECM and CAM play an important role inthe progression of liver cirrhosis after HCV infection. The capital mechanism is related to the inflammatory cellsinfiltration, the activation and transformation of ECM producing cells and the imbalance between production and elimination of ECM. AIM:We aimed to observe the expression of extracellular matrix (ECM) and cellular adhesion molecules (CAM) in cirrhotic liver tissues after hepatitis C virus (HCV) infection. METHODS: Twelve patients with post HCV inflammatory liver cirrhosis were selected to evaluate their liver function and other virological,pathological parameters.Then three specimens of cirrhotic patients whose health assessment results and laboratory data were similar and three normal liver specimens explanted from liver grafts prepared for liver transplantation were chosen for investigating gene expression of ECM and CAM using cDNA expression array. RESULTS: The cDNA array assay revealed 36.7% (36/96) of genes with changes, in which 26.3% (26/96) was up-regulated and 10.1% (10/96) was down-regulated. Integrin (ITGA), collagen (COL), ADAMTS were identified as the characteristic changes of ECM and CAM gene expression levels. ITGA were demonstrated β1 and β2 sub-section changed in liver cirrhosis. CONCLUSION: ECM and CAM play an important role in the progression of liver cirrhosis after HCV infection. The capital mechanism is related to the inflammatory cells infiltration, the activation and transformation of ECM producing cells and the imbalance between production and elimination of ECM.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第14期2184-2187,共4页 世界胃肠病学杂志(英文版)
关键词 Hepatitis C virus Liver cirrhosis Extracellular matrix Cellular adhesion molecules mRNA array analysis ECM 细胞外表达 CAM 细胞支持分子 肝硬化 丙型肝炎 cDNA
  • 相关文献

参考文献12

  • 1Olga OZ, Nikolai DY. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements? Curr Pharm Biotechnol 2003; 4: 195-209.
  • 2Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL Jr, Katze MG. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 2003; 38: 1458-1467.
  • 3Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int 2003; 23: 63-69.
  • 4Raines EW. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relation ships to vascular disease. Int J Exp Pathol 2000; 81: 173-182.
  • 5Kozlowska J, Loch T, Jablonska J, Cianciara J. Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin. Przegl Epidemiol 2001; 55: 451-458.
  • 6Sobel RA. The extracellular matrix in multiple sclerosis: an update. Braz J Med Biol Res 2001; 34: 603-609.
  • 7Shimizu I. Antifibrogenic therapies in chronic HCV infection. Curr Drug Targets Infect Disord 2001; 1: 227-240.
  • 8Calabrese F, Valente M, Giacometti C, Pettenazzo E, Benvegnu L, Alberti A, Gatta A, Pontisso P. Parenchymal transforming growth factor beta-1: its type Ⅱ receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology. J Gastroenterol Hepatol 2003; 18:1302-1308.
  • 9Quondamatteo F, Kempkensteffen C, Miosge N, Sonnenberg A, Herken R. Ultrastructural localization of integrin subunits a3 and a6 in capillarized sinusoids of the human cirrhotic liver. Histol Histopathol 2004; 19: 799-806.
  • 10Oda T, Jung YO, Kim HS, Cai X, Lopez-Guisa JM, Ikeda Y, Eddy AA. PAI -1deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 2001; 60: 587-596.

同被引文献17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部